Sandimmune and Atelectasis - a phase IV clinical study of FDA data

Summary:

Atelectasis is reported as a side effect among people who take Sandimmune (cyclosporine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Prednisolone, and have Eczema.

The phase IV clinical study analyzes which people have Atelectasis when taking Sandimmune. It is created by eHealthMe based on reports of 6,679 people who have side effects when taking Sandimmune from the FDA, and is updated regularly.

What is Sandimmune?

Sandimmune has active ingredients of cyclosporine. eHealthMe is studying from 6,694 Sandimmune users. Check the latest studies of Sandimmune.

What is Atelectasis?

Atelectasis (partial or complete collapse of the lung) is found to be associated with 1,441 drugs and 1,637 conditions by eHealthMe. Check the latest studies of Atelectasis.

On Aug, 07, 2026

6,679 people reported to have side effects when taking Sandimmune.
Among them, 19 people (0.28%) have Atelectasis.

Among these 19 people:

How long have people been on Sandimmune when they have Atelectasis? *

What is the gender of people who have Atelectasis when taking Sandimmune? *

female: 61.11 %
male: 38.89 %

What is the age of people who have Atelectasis when taking Sandimmune? *

What are other drugs people take besides Sandimmune? *

What are other side effects people have besides Atelectasis? *

Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 9 people, 47.37%
Pleural Effusion (water on the lungs): 8 people, 42.11%
Fever: 7 people, 36.84%
Pneumonia: 7 people, 36.84%
Dyspnea (difficult or laboured breathing): 6 people, 31.58%
Weight Decreased: 5 people, 26.32%
Hypotension (abnormally low blood pressure): 5 people, 26.32%
Pulmonary Haemorrhage (acute bleeding from the lung): 5 people, 26.32%
Septic Shock (shock due to blood infection): 4 people, 21.05%
Pulmonary Oedema (fluid accumulation in the lungs): 4 people, 21.05%

What are the existing conditions these people have? *

Immunodeficiency Disorders: 2 people, 10.53%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 10.53%
Gastritis (inflammation of stomach): 2 people, 10.53%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 10.53%
Osteoporosis (bones weak and more likely to break): 1 person, 5.26%
Metastases To Bone (cancer spreads to bone): 1 person, 5.26%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.26%
Bone Loss: 1 person, 5.26%
Blood Stem Cell Harvest: 1 person, 5.26%
Aplastic Anemia: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Sandimmune and have Atelectasis?

- Check whether Atelectasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sandimmune:

Sandimmune (6,694 reports)

Atelectasis treatments and more:

Atelectasis (17,087 reports)

Browse all side effects of Sandimmune:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atelectasis:

Atelectasis (1,441 drugs)

Browse all the conditions that are associated with Atelectasis:

Atelectasis (1,637 conditions)

Related publications that referenced our studies

O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on cyclosporine (the active ingredients of Sandimmune) and Sandimmune (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.